Olfactory dysfunction and dementia in Parkinson's disease

Journal of Parkinson's Disease

Volumn 4, Issue 2, 2014, Pages 181-187

  Takeda, Atsushi ^a   Baba, Toru ^b   Kikuchi, Akio ^c   Hasegawa, Takafumi ^c   Sugeno, Naoto ^c   Konno, Masatoshi ^c   Miura, Emiko ^a   Mori, Etsuro ^b  

^a SENDAI CITY MEDICAL CENTER   (Japan)

^b Department of Behavioral Neurology and Cognitive Neuroscience ^*  (Japan)

^c TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Hyposmia; MRI; OSIT J; Parkinson's disease with dementia; PET

Indexed keywords

DONEPEZIL; DOPAMINE; FLUORODEOXYGLUCOSE;

AMYGDALOID NUCLEUS; ARTICLE; ATROPHY; CLINICAL FEATURE; DEMENTIA; DISEASE ASSOCIATION; DOPAMINE BRAIN LEVEL; FRONTAL LOBE; HUMAN; HYPOSMIA; JAPANESE (PEOPLE); LONGITUDINAL STUDY; NEUROLOGIC EXAMINATION; NUCLEAR MAGNETIC RESONANCE IMAGING; OCCIPITAL LOBE; ODOR STICK IDENTIFICATION TEST FOR JAPANESE; OLFACTORY CORTEX; PARKINSON DISEASE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK FACTOR; SCORING SYSTEM; AGED; BRAIN; COMPLICATION; FEMALE; MALE; METABOLISM; MIDDLE AGED; OLFACTION DISORDERS;

AGED; BRAIN; DEMENTIA; FEMALE; HUMANS; MALE; MIDDLE AGED; OLFACTION DISORDERS; PARKINSON DISEASE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RISK FACTORS;

EID: 84901840169     PISSN: 18777171     EISSN: 1877718X     Source Type: Journal    
DOI: 10.3233/JPD-130277     Document Type: Article

References (35)

1. Parkinson J (2002) An essay on the shaking palsy. 1817. J Neuropsychiatry Clin Neurosci 14, 223-236; discussion 222.
2. Weintraub D, & Burn DJ (2011) Parkinson's disease: The quintessential neuropsychiatric disorder. Mov Disord, 26, 1022-1031.
3. Poewe W, Gauthier S, Aarsland D, Leverenz JB, Barone P, Weintraub D, Tolosa E, & Dubois B (2008) Diagnosis and management of Parkinson's disease dementia. Int J Clin Pract, 62, 1581-1587.
4. Burn DJ (2010) The treatment of cognitive impairment associated with Parkinson's disease. Brain Pathol, 20, 672-678.
5. Johansen KK, White LR, Sando SB, & Aasly JO (2010) Biomarkers: Parkinson disease with dementia and dementia with Lewy bodies. Parkinsonism Relat Disord, 16, 307-315.
6. Forsaa EB, Larsen JP, Wentzel-Larsen T, & Alves G (2010) What predicts mortality in Parkinson disease? A prospective population-based long-term study. Neurology, 75, 1270-1276.
7. Baba T, Takeda A, Kikuchi A, NishioY, HosokaiY, Hirayama K, Hasegawa T, Sugeno N, Suzuki K, Mori E, Takahashi S, Fukuda H, & Itoyama Y (2011) Association of olfactory dysfunction and brain. Metabolism in Parkinson's disease. Mov Disord, 26, 621-628.
8. Baba T, Kikuchi A, Hirayama K, Nishio Y, Hosokai Y, Kanno S, Hasegawa T, Sugeno N, Konno M, Suzuki K, Takahashi S, Fukuda H, Aoki M, Itoyama Y, Mori E, & Takeda A (2012) Severe olfactory dysfunction is a prodromal symptom of dementia associated with Parkinson's disease: A 3 year longitudinal study. Brain, 135, 161-169.
9. Langston JW (2006) The Parkinson's complex: Parkinsonism is just the tip of the iceberg. Ann Neurol, 59, 591-596.
10. Litvan I, Aarsland D, Adler CH, Goldman JG, Kulisevsky J, Mollenhauer B, Rodriguez-Oroz MC, Troster AI, & Weintraub D (2011) MDS task force on mild cognitive impairment in Parkinson's disease: Critical review of PD-MCI. Mov Disord, 26, 1814-1824.
11. Emre M, Aarsland D, Brown R, Bum DJ, Duyckaerts C, Mizuno Y, Broe GA, Cummings J, Dickson DW, Gauthier S, Goldman J, Goetz C, Korczyn A, Lees A, Levy R, Litvan I, McKeith I, Olanow W, Poewe W, Quinn N, Sampaio C, Tolosa E, & Dubois B (2007) Clinical diagnostic criteria for dementia associated with Parkinson's disease. Mov Disord, 22, 1689-1707.
12. Dubois B, Burn D, Goetz C, Aarsland D, Brown RG, Broe GA, Dickson D, Duyckaerts C, Cummings J, Gauthier S,Korczyn A, Lees A, Levy R, Litvan I, Mizuno Y, McKeith IG, Olanow CW, Poewe W, Sampaio C, Tolosa E, & Emre M (2007) Diagnostic procedures for Parkinson's disease dementia: Recommendations from the movement disorder society task force. Mov Disord, 22, 2314-2324.
13. Burn DJ, Rowan EN, Allan LM, Molloy S, O'Brien JT, & McKeith IG (2006) Motor subtype and cognitive decline in Parkinson's disease, Parkinson's disease with dementia, and dementia with Lewy bodies. J Neurol Neurosurg Psychiatry, 77, 585-589.
14. Taylor JP, Rowan EN, Lett D, O'Brien JT, McKeith IG, & Burn DJ (2008) Poor attentional function predicts cognitive decline in patients with non-demented Parkinson's disease independent of motor phenotype. J Neurol Neurosurg Psychiatry, 79, 1318-1323.
15. Vendette M, Gagnon JF, Decary A, Massicotte-Marquez J, Postuma RB, Doyon J, Panisset M, & Montplaisir J (2007) REM sleep behavior disorder predicts cognitive impairment in Parkinson disease without dementia. Neurology, 69, 1843-1849.
16. Doty RL, Deems DA, & Stellar S (1988) Olfactory dysfunction in parkinsonism:Ageneral deficit unrelated to neurologic signs, disease stage, or disease duration. Neurology, 38, 1237-1244.
17. Doty RL (2007) Olfaction in Parkinson's disease. Parkinsonism Relat Disord, 13(Suppl 3), S225-S228.
18. Ansari KA,&JohnsonA(1975) Olfactory function in patients with Parkinson's disease. J Chronic Dis, 28, 493-497.
19. Hubbard PS, Esiri MM, Reading M, McShane R, & Nagy Z (2007) Alpha-synuclein pathology in the olfactory pathways of dementia patients. J Anat, 211, 117-124.
20. Silveira-Moriyama L, Holton JL, Kingsbury A, Ayling H, Petrie A, SterlacciW, PoeweW, Maier H, Lees AJ, & Revesz T (2009) Regional differences in the severity of Lewy body pathology across the olfactory cortex. Neurosci Lett, 453, 77-80.
21. Wattendorf E, Welge-Lussen A, Fiedler K, Bilecen D, WolfensbergerM,Fuhr P,HummelT,&WestermannB(2009) Olfactory impairment predicts brain atrophy in Parkinson's disease. J Neurosci, 29, 15410-15413.
22. Morley JF, Weintraub D, Mamikonyan E, Moberg PJ, Siderowf AD, & Duda JE (2011) Olfactory dysfunction is associated with neuropsychiatric manifestations in Parkinson's disease. Mov Disord, 26, 2051-2057.
23. Parekh V (2011) Parkinson disease: Sniffing out dementia. Nat Rev Neuro, 7, 358.
24. Docherty MJ, & Burn DJ (2010) Parkinson's disease dementia. Curr Neurol Neurosci Rep, 10, 292-298.
25. Saito S, Ayabe-Kanamura S, Takashima Y, Gotow N, Naito N, Nozawa T, Mise M, Deguchi Y, & Kobayakawa T (2006) Development of a smell identification test using a novel sticktype odor presentation kit. Chem Senses, 31, 379-391.
26. Bohnen NI, Muller ML, Kotagal V, Koeppe RA, Kilbourn MA, Albin RL, & Frey KA (2010) Olfactory dysfunction, central cholinergic integrity and cognitive impairment in Parkinson's disease. Brain, 133, 1747-1754.
27. Westermann B, Wattendorf E, Schwerdtfeger U, Husner A, Fuhr P, Gratzl O, Hummel T, Bilecen D, & Welge-L̈ussen A (2008) Functional imaging of the cerebral olfactory system in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry, 79, 19-24.
28. Takeda A, Saito N, Baba T, Kikuchi A, Sugeno N, Kobayashi M, Hasegawa T, & Itoyama Y (2010) Functional imaging studies of hyposmia in Parkinson's disease. J Neurol Sci, 289, 36-39.
29. Hirano S, Shinotoh H, & Eidelberg D (2012) Functional brain imaging of cognitive dysfunction in Parkinson's disease. J Neurol Neurosurg Psychiatry, 83, 963-969.
30. Rolinski M, Fox C, Maidment I, & McShane R (2012) Cholinesterase inhibitors for dementia with Lewy bodies, Parkinson's disease dementia and cognitive impairment in Parkinson's disease. Cochrane Database Syst Rev, 3, CD006504.
31. Kempster PA, O'Sullivan SS, Holton JL, Revesz T, & Lees AJ (2010) Relationships between age and late progression of Parkinson's disease:Aclinico-pathological study. Brain, 133, 1755-1762.
32. Dubois B, Tolosa E, Katzenschlager R, Emre M, Lees AJ, Schumann G, Pourcher E, Gray J, Thomas G, Swartz J, Hsu T, & Moline ML (2010) Donepezil in Parkinson's disease dementia: A randomized, double-blind efficacy and safety study. Mov Disord, 27, 1230-1238.
33. Mori E, Ikeda M,&Kosaka K (2012) Donepezil for dementia with Lewy bodies: A randomized, placebo-controlled trial. Ann Neurol, 72, 41-52.
34. Chung KA, Lobb BM, Nutt JG,&Horak FB (2010) Effects of a central cholinesterase inhibitor on reducing falls in Parkinson disease. Neurology, 75, 1263-1269.
35. Rochester L, Yarnall AJ, Baker MR, David RV, Lord S, Galna B, & Burn DJ (2012) Cholinergic dysfunction contributes to gait disturbance in early Parkinson's disease. Brain, 135, 2779-2788.